New drugs in the therapy of colorectal cancer
Bajetta, E.; Cassata, A.; Cortinovis, D.
Tumori 87(1 Suppl 1: S3-S4
2001
ISSN/ISBN: 0300-8916 PMID: 11300017 Document Number: 527515
Document emailed within 1 workday
Related Documents
Kato, K. 2011: Development of oral drugs in the standard therapy for metastatic colorectal cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 454-458Harboe, K.; Todnem, K.; Zotova, L.; Lind, A.; Ogreid, D. 2000: New drugs in the treatment of advanced colorectal cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(23): 2777-2780
Farmer, K.C.; Goulston, K.; Macrae, F. 1993: Aspirin and non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer Medical Journal of Australia 159(10): 649-650
Benamouzig, R. 1998: Do aspirin or nonsteroidal anti-inflammatory drugs decrease the risk of colorectal cancer? Gastroenterologie Clinique et Biologique 22(3 Suppl): S22-S27
Herbert, C. 1998: Diet and nonsteroidal anti-inflammatory drugs: role in prevention of colorectal cancer Gastroenterologie Clinique et Biologique 22(3 Suppl): S202-S217
Jankilevich, G. 2005: Therapy for colorectal cancer New England Journal of Medicine 352(17): 1820-1822; Author Reply 1820-1822
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Rajpal, S.; Venook, A.P. 2006: Targeted therapy in colorectal cancer Clinical Advances in Hematology and Oncology: H&o 4(2): 124-132
Hwang, J.; Marshall, J.L. 2006: Targeted therapy for colorectal cancer Current Opinion in Investigational Drugs 7(12): 1062-1066
Benson, A.B. 1998: Therapy for advanced colorectal cancer Seminars in Oncology 25(5 Suppl 11: 2-11
Marshall, J.L. 2014: Maintenance therapy in metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 12(6): 388-390
Peeters, M.; Haller, D.G. 1999: Therapy for early-stage colorectal cancer Oncology 13(3): 307
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481
Yamaguchi, T.; Takahashi, T.; Kitamura, K.; Otsuji, E.; Kotani, T.; Kato, M.; Yata, Y.; Okamoto, K.; Nishi, H.; Ichikawa, D.; Yamamoto, K. 1996: Diagnosis and targeting therapy of colorectal cancer using antibody Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(5): 549-553
O'Connell, M.J. 2004: Current status of adjuvant therapy for colorectal cancer Oncology 18(6): 751
Safi, F.; Beger, H.G. 1994: Morbidity and mortality in surgical therapy of colorectal cancer Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(2): 127-131
Pasetto, L.Maria.; Bortolami, A.; Falci, C.; Sinigaglia, G.; Monfardini, S. 2006: Recent progress in target therapy in colorectal cancer Anticancer Research 26(5b): 3973-3981
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ishida, H.; Fujioka, M.; Ohsawa, T.; Takeuchi, I.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2001: Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1624-1627